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ABSTRACT
The optic chiasm is a key anatomic structure along the visual pathway, situated at the
crossroads between the optic nerves and tracts. A wide range of diseases can affect the
optic chiasm and its surrounding strategic region at the base of the brain. Management
strategies for optic chiasm abnormalities vary substantially, depending on the abnormalities
revealed on neuroimaging. Scant attention has been paid to date to the comprehensive
classification of neuroimaging manifestations of optic chiasm abnormalities. We compre-
hensively reviewed and presented the imaging findings in a wide spectrum of pathologies
that originate from or involve the optic chiasm. This review will aid in differentiating the
many neuroimaging appearances of lesions in this region.
Learning Objective: List the lesions that involve the optic chiasm and classify them accord-
ing to their etiology.
INTRODUCTION
The optic chiasm is a key anatomic struc-
ture along the visual pathway, situated at
the crossroads between the optic nerves
and tracts. As is the case for many ana-
tomic names, its structure defines its name:
“chiasma” is indeed derived from the
Greek ´, meaning “to mark with an
X” (after the Greek letter ), which is the
shape of the chiasm when looked at from
above or below. The optic nerves come to-
gether within the chiasma to allow the
crossing of fibers from the nasal retina to
the contralateral optic tract; this enables
visual inputs from the nasal half of the eye
to be processed by the contralateral occip-
ital lobe. It is estimated that approximately
53% of fibers cross within the optic chi-
asm.1 The intracranial course of the optic
tracts arises from the posterior aspect of
the chiasm, with an angle between 15° and
45°.
When looking at the regional anatomy
(Fig 1), the chiasm sits just below the hy-
pothalamus, overlies the tuberculum sellae
of the sphenoid bone and the pituitary
gland, and lies within the wall of the third
ventricle; it is surrounded by CSF, with the
chiasmatic cistern being just anterior. The
infundibulum of the pituitary lies immedi-
ately posteriorly, and the mammillary bod-
ies are behind this, medial to the 2 optic
tracts. The optic chiasm also lies at a cross-
roads of blood vessels; the internal carotid
arteries lie on either side, and the anterior
communicating artery is just directly above
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the chiasm. The blood supply of the chiasm can be quite
variable. In most cases, the feeder vessels are branches of the
anterior communicating artery, anterior cerebral, posterior
communicating, posterior cerebral, and basilar arteries. How-
ever, there are many collateral vessels, so infarction of the
chiasm is extremely rare. In viewof the complex anatomic and
topographic landmarks adjacent to the chiasm, a wide range
of diseases can affect this structure. Scant attention has been
paid to the comprehensive classification of the neuroimaging
manifestations of optic chiasm abnormalities. In this review,
we addressed the neuroimaging findings of lesions that involve
the chiasm and classify them according to their etiology.
CONGENITAL AND IATROGENIC LESIONS
Intrinsic Lesions
Ocular Albinism. Albinism is a rare congenital disorder
characterized by a defective synthesis of melanin from ty-
rosine or its complete absence, which results from the mu-
tation of 1 or more associated genes. The consequence of
such mutations is a partial or complete absence of pigment
in the skin, hair, and eyes. Varying degrees of hypopigmen-
tation occur, owing to different mutation types, which give
rise to phenotypic heterogeneity.2 Ocular albinism, an X-
chromosome-linked disorder, results in the reduction or
absence of melanin only in the eyes, with the melanocytic
system offering normal pigmentation to the rest of the
body.3 It is associated with several visual defects, such as
decreased visual acuity, monocular vision and photopho-
bia, foveal hypoplasia, and congenital misrouting of fibers
within the chiasm. Quantitative testing of visual evoked
potentials usually demonstrates this misrouting at the chi-
asmatic level. Patients with albinism show an asymmetry of
visual evoked potentials between the 2 eyes, secondary to
misrouting of the optic pathways. Indeed, achiasma (see
Nondecussating Retinal–Fugal Fiber Syndrome) has rarely
been reported in patients with albinism.2MR imaging has a
limited potential in assessing this misrouting; however, it
has shown that humans with albinism have significantly
smaller chiasmatic widths, smaller optic nerves and tracts,
and wider angles between nerves and tracts. The size and
configuration of the optic chiasm are distinctly different
from those in healthy subjects.4
NondecussatingRetinal–Fugal Fiber Syndrome.Nondecussat-
ing retinal–fugal fiber syndrome, also called achiasma, is
extremely rare and may occur with or without nystagmus.
The optic chiasm is absent, with normal appearances of the
remaining structures of the visual pathway. In achiasma,
there is a disruption of retinal-fugal projections, as well as
diminished organization and function throughout the vi-
sual pathways. Because of the absence of the optic chiasm,
all nasal fibers fail to decussate, thereby misprojecting and
malaligning with projections of the temporal retina of the
same eye. Monocular visual evoked potentials reveal “mir-
ror reversely” interocular ipsilateral asymmetry.5 Besides
nondecussating retinal–fugal fiber syndrome, achiasma or
hypochiasmia has been reported in patients with congenital
anophthalmos and with midline anomalies, and in patients
with albinism.5 MR imaging shows a complete absence (or
partial absence in patients with hypochiasmia) of the optic
chiasm, with the optic nerves transitioning into the optic
tracts. Functional MR imaging confirms electrophysiologic
observations of crossed asymmetry, with each ocular cortex
receiving a complete but monocular visual field. Despite
these abnormalities, vision is normally preserved because of
a reorganization of intracortical connections.5
Radiation Necrosis. Radiation necrosis of the optic chiasm
is extremely rare; however, it may be caused by radiation
therapy for pituitary adenomas or other regional malignant
lesions. It may involve normal tissues and may mimic recur-
rent disease on both the clinical presentation and follow-up
imaging studies.6 Visual loss is the main symptom and,
when it occurs in a patient who has undergone surgery for a
sellar, parasellar, or skull base tumor with adjuvant radia-
tion therapy, the clinical presentationmay be helpful for the
Fig 1. Anatomyof theoptic chiasm.Coronal (A) and sagittal (B) viewsof theoptic chiasmand the surrounding structures. (Reproducedwithpermission
from Di Ieva A, Rotondo F, Syro LV, et al. Aggressive pituitary adenomas–diagnosis and emerging treatments. Nat Rev Endocrinol 2014;10:423–35.)
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differential diagnosis. Visual loss owing to radiation-in-
duced optic neuropathy, in fact, causes a rapid deteriora-
tion in days to weeks, whereas recurrent or progressive
tumors or arachnoidal adhesions around the chiasm, which
can cause visual symptoms as well, produce more slowly pro-
gressive visual impairment. After radiation therapy, peak oc-
currence of radiation necrosis is between 12 and 18 months,
with most cases occurring within 36 months.6 Contrast-en-
hanced MR imaging of the orbits, optic nerves, and chiasm is
indispensable for the early diagnosis of radiation necrosis,
which is not visualized on CT. MR imaging can demonstrate
widespread gadolinium-enhanced lesions in the optic chiasm,
optic tract, and hypothalamus. A thickening of the chiasm can
also be seen.7Optic nerve enhancement in apatientwith visual
loss and a history of radiation therapy to the orbits or optic
nerves indicates radiation optic neuropathy.6
Extrinsic Lesions
Mucoceles.Amucocele is an accumulation of mucoid secre-
tion through the sphenoid sinus (eg, either congenital, post-
traumatic, or idiopathic). Fewer than 3% of all paranasal
sinus lesions occur in the sphenoid sinus, and an isolated
sphenoid sinus mucocele is extremely rare.8 Symptoms are
nonspecific, which thus results in a delay in diagnosis and
may arise from mechanical pressure on neighboring struc-
tures and/or the involvement of nerves and the chiasm in the
inflammatory process. The most common symptoms in-
clude headache, visual loss, and palsies of cranial nerves III
and IV.9-11 However, oculomotor nerve palsy is rare.12 This
is thought to be due to the direct compressive effects of the
expansible mucocele on the nerves. Current treatment is by
endoscopic sphenoidotomy and drainage of the muco-
cele.9,10 Rapidly treated disease usually allows the return of
ocular nerve function. However, recurrence is not uncom-
mon, and, therefore, strict follow-up of patients is recom-
mended.8 Mucoceles may have variable densities on CT as
well as intensities on MR imaging, depending on their pro-
tein content and possible superinfection.12 On CT images,
they appear as an opacification of the affected sphenoid
sinus, with bony expansion, with or without erosion. MR
imaging findings include the following: on T1WIs, they are
hypointense to hyperintense according to their proportion
of water, mucus, and protein (if predominantly water: hy-
pointense; if predominantly protein: hyperintense). On
T2WIs, signal intensity is opposite that of T1WIs. Postg-
adolinium enhancement can be seen at the periphery.
NON NEOPLASTIC LESIONS
Intrinsic Lesions
Choristomas. Choristomas are uncommon cystic lesions
composed of adipose tissue and smooth muscle that involve
the optic nerve. To date, only a few cases have been re-
ported in the literature. Choristomas can rarely affect the
optic chiasm or tracts and the pituitary gland. This lesion is
most likely a non neoplastic malformation, and it can cause
progressive visual loss.13 Because of the high adipose tissue
content in the lesion, pathologic confirmation is often re-
quired for the diagnosis, even though MR imaging may be
highly suggestive.13 OnMR imaging, these are well-defined
masses, with signal intensity of the tissue contained within
the lesion being quite nonspecific; there is vivid enhance-
ment after gadolinium administration. Even if imaging
studies are highly suggestive of the diagnosis, then patho-
logic confirmation is required because of the high adipose
tissue content in most cases.
Extrinsic Lesions
Suprasellar Arachnoid Cysts. Suprasellar arachnoid cysts
are benign lesions that share all the features of other arach-
noid cysts. They are not infrequent and present with signs of
compression of the surrounding structures (including the
chiasm), which may lead to hypothalamic dysfunction and
hydrocephalus.14 It can be difficult with imaging to differ-
entiate these lesions from other cystic lesions, for example,
Rathke cleft cysts,15 and the diagnosis is often made only at
surgery. Treatment involves incision and fenestration of the
cysts, with a low risk of recurrence. On MR imaging, they
present as cystic lesions with thin walls, no solid compo-
nent, and no enhancement after gadolinium administration.
However, they may be challenging to diagnose when lo-
cated in the suprasellar region.
Rathke Cleft Cysts. Rathke cleft cysts are benign epitheli-
um-lined intrasellar cysts that contain mucoid material.16
They are thought to originate from the invagination of the
Rathke pouch, which is the precursor of the anterior and
posterior lobes of the pituitary gland.Most are sellar lesions
but may extend to, or arise from, the suprasellar region.
They are twice as common in women than in men and are
usually incidentally diagnosed in adults between 40 and 60
years old.15 Most are asymptomatic and do not enlarge.
Occasionally, they become large enough to cause symptoms
that include visual loss owing to chiasmal compression,
hypopituitarism, and headache.16 The treatment of choice
is the endoscopic transsphenoidal drainage and marsupial-
ization of the cyst.14 Imaging characteristics are variable,
and they are usually included as a differential diagnosis for
suprasellar cystic lesions. Unenhanced CT demonstrates a
noncalcified cyst with low attenuation, with no enhance-
ment after contrast medium administration, though some
sporadic cases of contrast enhancement have been reported.
OnMR imaging, the signal intensity varies according to the
composition of the fluid within the cyst (Fig 2). Cysts with
low protein content are isointense with CSF on all sequences;
however, as the protein content rises, these cysts become
hyperintense on T1 images15; on T2, they are usually hy-
perintense, and there is no enhancement after gadolinium
administration; however, it is possible to see a rim of en-
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hancement that represents the pituitary tissue displaced and
compressed by the cyst. In contrast with craniopharyngio-
mas, Rathke cleft cysts do not calcify.
INFLAMMATORY DISEASES
Intrinsic Lesions
Multiple Sclerosis. MS is a chronic inflammatory demyeli-
nating disease of the CNS of unknown etiology that usually
affects young and middle-aged adults. MS presents with
clinical manifestations, such as impaired sensory andmotor
functions, and cognitive, urogenital, visual, and mental dis-
orders that may alternate with periods of remission and
exacerbation. Acute optic neuritis occurs at some time dur-
ing the disease in 50% of patients, though it rarely affects
the chiasm.17 Other ocular or visual findings include the
following: retinitis, uveitis, peripheral vasculitis, decreased
visual function, nystagmus, internuclear ophthalmoplegia,
diplopia, optic papillitis, and Marcus Gunn pupil.18 Optic
neuritis, the most important ocular manifestation ofMS, is an
inflammatory injury of the optic nerves and represents the
initial symptom in 20%of patientswith the disease. Diagnosis
is essentially clinical, though MR imaging, CSF analysis, and
evoked potential studies are routinely used for confirmation.
MR imaging is the method of choice for the diagnosis because
it can show multiple lesions (dissemination in space) and new
lesions in follow-up scans (dissemination in time), according
to the McDonald criteria for MS and their revisions19,20 and
theMagneticResonance Imaging inMultiple Sclerosis consen-
sus guidelines.21 MR imaging can reveal swelling and en-
hancement of the optic chiasm in the acute phase; theremaybe
atrophy in patients with long-standing disease. In optic neuri-
tis, the optic nerves appear hyperintense and swollen on T2-
weighted sequences, and enhance on T1-weighted sequences
after gadolinium administration.
Sarcoidosis. Sarcoidosis is an autoimmune disorder of un-
certain etiology in which granulomatous inflammation de-
velops and leads to tissue destruction and fibrosis.14 It can
spread to the CNS through infiltration of meningeal spaces
and may involve the anterior visual pathway at any level.
Indeed, visual system abnormalities are the most common
extrathoracic manifestations of sarcoidosis, with extraocu-
larmuscles, retrobulbar space, optic nerves, the chiasm, and
optic radiations that may be affected.22 Granulomas may
arise within the disc, and the optic nerve is commonly in-
volved, where an intrinsic lesion may develop and lead to
the clinical syndrome of optic neuritis.23 Compression by
an inflammatorymass at the orbital apex or, less frequently,
at the cavernous sinus, may occur24 and can be associated
with ophthalmoparesis and trigeminal neuropathy. Corti-
costeroids are the mainstay of treatment, but additional
immunosuppressive therapy is required in some patients.23
MR imaging is the technique of choice and gadolinium-
enhanced T1-weighted sequences are the most important
(Fig 3). Imaging features are variable according to the dif-
ferent locations of involvement. Invasion of the leptomenin-
ges is seen as contrast enhancement, the dura mater can be
thickened, and involvement of the parenchyma can mimic a
pseudotumor lesion. In many patients, some combination
of neural optic or perineural enhancement is noted after
gadolinium administration.22 The coexistence of multiple
locations is suggestive of sarcoidosis.
Idiopathic Optic Chiasmitis. Chiasmal neuritis is a clinical
syndrome that consists of acute visual loss with a chiasmal
visual field pattern and/or radiographic demonstration of
chiasmal inflammation.25 Occasional cases of chiasmal
neuritis are due to a systemic inflammatory disease, such as
tuberculosis (TB), sarcoidosis, systemic lupus erythemato-
sus, Epstein-Barr disease, or Lyme disease. It is rare, often
diagnosed only after having ruled out other pathologies.
However, more commonly, chiasmal disease occurs as an
idiopathic event. In such cases, it is a rare disorder whose
clinical profile is not well characterized, even if, most
commonly, patients present with painless monocular visual
loss or bitemporal hemianopia.25 Treatment includes oral
and/or IV corticosteroids. MR imaging reveals chiasm
swelling in most cases, with or without enhancement, and
with lesions in the white matter as well.
Extrinsic Lesions
Antineutrophil Cytoplasmic Antibody Positive Vasculitis.
Antineutrophil cytoplasmic antibody positive vasculitis is a
granulomatous inflammatory disorder with features of
venular and arteriolar perivasculitis, and it affects the lungs,
Fig 2. Rathke cleft cyst. Sagittal (A) and coronal (B) T1WI and sagittal (C) postgadolinium T1WI of a Rathke cleft cyst. A 37-year-old woman with
headache. The MR imaging demonstrates a T1-hyperintense, nonenhancing lesion in the pituitary gland, consistent with an incidental Rathke cyst.
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skin, eyes, and kidneys. Included in this disease group are
granulomatosis with polyangiitis, formerly known as We-
gener granulomatosis, microscopic polyangiitis, and eosin-
ophilic granulomatosis with polyangiitis (Churg-Strauss
syndrome) that involve small vessels (both arteries and
veins). Neurologic involvement arises as a hypertrophic
pachymeningitis, as an isolated inflammatory mass, or as a
central or peripheral manifestation of inflammatory perivasc-
ulitis.26 InWegener granulomatosis, for example, it is thought
that granulomatous tissue may spread out from the nasal or
paranasal cavities, which are mainly involved, and invade the
adjacent structures, such as the orbit, optic nerves, chiasm,
and/or pituitary gland.26 MR imaging can detect an enlarged
and gadolinium-enhancing pituitary gland, a thickening of the
pituitary stalk and, inconstantly, the loss of the normal poste-
rior lobe hyperintensity on T1-weighted sequences.26
Lymphocytic Hypophysitis. Lymphocytic hypophysitis is a
rare autoimmune disease of the pituitary gland, which can
present with varying grades of pituitary hormonal impair-
ment and/or with symptoms related to pituitary enlarge-
ment.27 It affects women more frequently than men, with a
reported ratio of 5:1, and occurs in the later stages of preg-
nancy or early postpartum.27 Some patients in the early
stages of the disease may present with clinical signs and
symptoms due to pituitary enlargement, with possible ex-
trasellar extension, including headache, visual field impair-
ment, and, more rarely, diplopia, with or without hypopi-
tuitarism.27 Hyperprolactinemia is a usual finding, even
though sometimes prolactin levels can be normal or even
reduced.28 Anti-inflammatory and/or immunosuppressive
drugs can be effective to reduce the size of the pituitary
mass. In patients with lymphocytic hypophysitis and with
signs and symptoms related to pituitary enlargement, MR
imaging is particularly important to differentiate this disor-
der from adenoma, even if imaging findings sometimes tend
to overlap (Fig 4). Patients with lymphocytic hypophysitis
usually have pituitary enlargement, with a symmetric su-
prasellar extension, which can displace the optic chiasm,
whereas patients with adenoma have asymmetric pituitary
Fig 3. Sarcoid hypophysitis. Axial T1WI (A) and T2WI (B) and postgadolinium axial (C) and coronal T1WI (D) of a patient with hypophysitis. A
49-year-old woman with a history of progressive dizziness. MR imaging demonstrates an enlargement of the pituitary, with upward bulging into the
suprasellar cistern, touching the optic chiasm; appearances may be the result of hypophysitis due to involvement by sarcoidosis.
Fig 4. Lymphocytic hypophysitis. Axial T2WI (A) and coronal (B) and sagittal (C and D) postgadolinium T1WI of a patient with lymphocytic hypophy-
sitis. A 31-year-old postpartum woman with headache, fatigue, and vision loss. Axial T2 (A), coronal T1 (B), and sagittal T1 postcontrast (C) images
demonstrate a large sellar-suprasellar mass, with superior displacement of the optic chiasm—features that mimic a pituitary macroadenoma. During
surgery, the appearance of the gland was inflammatory and a biopsy was obtained, which demonstrated attenuated infiltrate of the B and T lympho-
cytes, consistent with the diagnosis of lymphocytic hypophysitis. Sagittal T1 postgadolinium image (D) obtained as part of follow-up MR imaging 3
weeks after starting steroid treatment demonstrates an interval decrease in size of the sellar-suprasellarmass, aswell as postsurgical changes related
to the trans-sphenoidal approach.
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enlargement with a deviation in the stalk, which is thick-
ened but usually not deviated in lymphocytic hypophysitis.
After gadolinium administration, pituitary enhancement is
homogeneous in lymphocytic hypophysitis, with a rim of
enhancing tissue along the dura mater, the so-called dural
tail. However, adenomas have delayed and poor enhance-
ment, usually without the dural tail.27
Xanthomatous Hypophysitis. This is a rare inflammatory
disorder of the pituitary gland owing to lymphocytic and
histiocytic infiltration. Some investigators believe this to be
an incomplete form of Erdheim– Chester disease, in which a
histiocytic infiltration of the bones, lungs, and numerous
other tissues may arise.29 Neurologic complications are
mostly due to the involvement of the orbits, optic nerves,
and chiasm, but other areas, such as the skin, heart, kidney,
and skeletal muscle, may be affected as well.30 Imaging
shows a cystic lesion within the pituitary gland, which pre-
dominantly contains fluid.
Benign Neoplastic Extrinsic Lesions
Pituitary Adenomas. Pituitary adenomas are the most com-
mon type of pituitary disorder. They are benign neoplasms
that account for 10%–15% of all intracranial masses.31
The incidence of pituitary adenomas within the general
population is as high as 16.7%.32 They typically arise from
the epithelial cells of the anterior part of the gland and are
classified according to their size: microadenomas are de-
fined as neoplasms 1 cm contained in the sella turcica,
whereas macroadenomas (Fig 5) are neoplasms1 cm that
may be contained in the sella turcica but often extend to the
superior, inferior, or lateral extrasellar space. Furthermore,
pituitary adenomas may also be categorized as functional
or nonfunctional; functional lesions present with clinical
symptoms due to increased hormonal secretion. Nonfunc-
tional adenomas, however, usually present with mass
effect and are often incidental findings.33 Prolactinomas
comprise 40%–57% of all pituitary adenomas, followed by
nonfunctioning adenomas (28%–37%), growth hormone-
secreting adenomas (11%–13%), and adrenocorticotropic
hormone-secreting adenomas (1%–2%).31
Pituitary adenomas that secrete follicle-stimulating hor-
mone, luteinizing hormone, or thyroid-stimulating hor-
mone are rare.34 Pituitary adenomas may present clinically
in 3 different ways: syndromes of hormone hypersecretion
or deficiency, neurologicmanifestations due tomass effect, or
incidental findings on imaging performed for an unrelated is-
sue. They are the most common extrinsic lesions responsible
for chiasmal syndromes.31 Prolactinomas usually presentwith
galactorrhea and amenorrhea; adrenocorticotropic hormone–
and growth hormone–secreting tumors produce Cushing dis-
ease and acromegaly, respectively. Headache may be the only
prominent feature in up to 34%of patients.35 Themain treat-
ment goals are to reduce hormone hypersecretion and its clin-
ical manifestation, decrease tumor size to improve symptoms
due tomass effect, and correct hormone deficiency.Most pro-
lactinomas can bemanagedmedicallywith dopamine agonists
(bromocriptine and cabergoline), whereas medical manage-
ment of growthhormone– and adrenocorticotropic hormone–
secreting tumors is less effective than for prolactinomas, and
surgical resection through a trans-sphenoidal approach is the
treatment of choice. Nonfunctioning microadenomas and
macroprolactinomas in patientswhoare asymptomatic donot
require immediate treatment and may be observed with fol-
low-up MR imaging.
MR imaging is the mainstay of imaging for both micro-
and macroadenomas (Fig 5), and dedicated pituitary
sequences (thin sections, small field of view) are used. Con-
trast-enhanced MRIs have a sensitivity of 90%.36 On un-
enhanced images, some features include asymmetric bulki-
ness of the gland and remodeling of the floor of the sella,
and deviation of the infundibulum away from the lesion can
suggest the presence of an adenoma.36 Postgadolinium im-
ages typically show an area of delayed enhancement com-
pared with the rest of the gland, which enhances vividly.
Dynamic acquisition may help in identifying a small area of
delayed enhancement as per microadenomas. Macroadeno-
mas may behave differently due to areas of cystic changes,
necrosis, or hemorrhage. In particular, the solid compo-
nents may demonstrate vivid enhancement similar to the
normal gland.
Fig 5. Pituitary macroadenoma. Coronal (A and B) and sagittal (C) T1WIs of a pituitary macroadenoma before (A) and after (B and C) gadolinium
administration. An 85-year-old man with a history of bitemporal hemianopia. Images demonstrate a homogeneously enhancing anterior pituitary
mass with suprasellar extension, with superior deviation of the optic chiasm. The pituitary infundibulum is posteriorly displaced.
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Craniopharyngiomas. Craniopharyngiomas account for
approximately 3% of all primary intracranial tumors.37
They are benign lesions (World Health Organization grade
I) that arise from the squamous epithelium at the junction
between the infundibulum and the anterior part of the
gland; according to some investigators, these are remnants
of the Rathke pouch.14 There is a bimodal incidence, in
childhood and again in middle-to-late life, with clinical fea-
tures of a sellar or hypothalamic lesion. They usually lie
above or below the chiasm and are classified as ada-
mantinomatous, papillary, or mixed, with the first being the
most common.38 The lesion is usually cystic, with a viscid
oily fluid (referred to as “engine oil”). It is possible to also
demonstrate cholesterol clefts, calcium, and keratin within
the lesion. The most common symptoms are visual loss,
visual field deficits, and hypothalamic impairment. The sur-
gical approach depends on the size and the extent of the
tumor; some lesions can be accessed via a trans-sphenoidal
approach, whereas others require a craniotomy. Postoper-
ative radiation therapy is especially useful in the case of
incomplete resection and is associated with tumor regres-
sion or lack of recurrence.37 CT can demonstrate lesions
with different characteristics according to their main com-
ponents. Cystic lesions have attenuation similar to
CSF39; the solid component shows a soft-tissue attenua-
tion with vivid enhancement, and calcification can be
seen in 90% of patients, the adamantinomatous type. Of
note, calcification and cystic changes are not usually seen
in the papillary type. At MR imaging (Fig 6), the cystic
component is iso- to hyperintense to brain parenchyma
on T1WI, with high signal intensity on T2WI. The solid
component exhibits vivid enhancement after gadolinium
administration, and calcification can be seen with gradi-
ent-echo images or SWIs.
Dermoid and Epidermoid Cysts. Dermoid and epidermoid
cysts are dysembryogenic tumors that represent 1% of all
intracranial tumors.40 They are characterized by slow
growth and a benign course. Dermoid cysts are rare benign
lesions of the CNS that result from the sequestration of
totipotent cutaneous ectodermal cells into the developing
neural tube during neurulation.40,41 Unlike their slightly
more common epidermoid counterparts, which are often
laterally placed, dermoid cysts tend to occur in the mid-
line.14,40 Both dermoid and epidermoid cysts can develop
anywhere in the CNS; however, in the suprasellar region,
they usually present in the same way as a pituitary adenoma
or a craniopharyngioma, with visual loss due to optic
nerves and chiasm compression and hypothalamic dysfunc-
tion. Despite the benign nature of dermoid cysts, their rup-
ture is associated with chemical meningitis and seizures.14
Dermoids are hyperintense on T1WI and T2WI, which may
be secondary to intralesional fat (Fig 7). Epidermoids typi-
cally have fluid signal intensity on both T1-weighted and
T2-weighted sequences, but they show restricted diffusion.
Meningiomas. Meningiomas are benign lesions that arise
from the arachnoid cap cells.42 They are twice as common
in women as in men and arise more frequently in the second
half of life.14 They tend to be benign and slow-growing, but
some may show an infiltrative behavior with respect to the
surrounding tissues. Because of their locations, meningio-
mas of the clivus, sphenoid wings, and the olfactory groove
and optic nerve sheath can involve the chiasm,43 and pri-
mary optic nerve sheath meningiomas may grow backward
to involve the chiasm.42 Tuberculum sellae meningioma is a
distinct clinical entity that represents 5%–10% of all intra-
cranial meningiomas.14,44 Tuberculum sellae meningiomas
displace the optic pathways upward and laterally, and thus
occupy a subchiasmal location. Therefore, they must be
distinguished from the olfactory groove, sphenoid planum,
and anterior clinoid process lesions, which are often con-
sidered suprasellar tumors.44 They may present with pro-
gressive loss of vision and visual field defects. Treatment is
surgical, with the transcranial approach still considered the
criterion standard for suprasellar tumors. Despite this, the
extended endonasal trans-sphenoidal route has recently
been developed for some select cases (small tumors, no lat-
eral extension, no vascular encasement).44 On unenhanced
CT, meningiomas are usually hyperattenuated compared
with the normal brain parenchyma and show some calcifi-
cation; the enhancement is typically avid. CT can easily
highlight the hyperostosis in the underlying bone, which is
quite characteristic. At MR imaging (Fig 8), the lesion is
Fig 6. Craniopharyngioma. Axial T2WI (A) and coronal (B) and sagittal (C) postgadolinium T1WI, showing a craniopharyngioma. A 30-year-old man
with a history of craniopharyngioma. Images show a sellar-suprasellar lesion displacing the optic chiasm and the infundibulum.
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isointense to gray matter in most patients, both in T1WI
and in T2WI. As on CT, the postgadolinium administration
enhancement is quite vivid, and it is possible to appreciate a
dural tail, thickening, and enhancement of the dura adja-
cent to the lesion, which, although could also be seen in
other pathologies, is quite suggestive of meningiomas.
MALIGNANT NEOPLASTIC LESIONS
Intrinsic Lesions
Gliomas.Optic nerve gliomas represent approximately 2%
of all brain tumors.45 These tumors are categorized into be-
nign optic gliomas (pilocytic astrocytomas, neurofibromatosis
type 1) that typically occur in childhood and malignant
optic gliomas that occur in adulthood. Malignant optic and
chiasmatic gliomas are extremely rare and are classified
pathologically as anaplastic astrocytomas and glioblastomas
(GBMs).46 Approximately 40 cases of anterior optic pathway
GBM in adults have been reported in the literature, and only 5
of them were described to originate from the optic chiasm.46
GBMs may involve the chiasm, either primarily or by infiltra-
tion from the adjacent structures. A peculiar subset of GBM is
hypothalamic-optochiasmatic GBM, which is associated with
neurofibromatosis type 1 and involves the optic nerves, chi-
asm, and tracts. Early symptoms include blurred vision and
progressive loss of bitemporal visual fields; headache and peri-
orbital pain may also occur.47 Standard treatment for GBM is
combined chemoradiation therapy in most patients. Because
optic GBM infiltrates extensively and grows rapidly, the prog-
nosis is unfavorable. Reported survival ranges from 6 to 14
months after diagnosis.46 Dinh et al47 published a case of
chiasmatic GBM, with the patient surviving 14 months after
the onset of the symptoms, which is the longest survival of
suchpatients in the literature.MR imaging can show the lesion
with subsequent enlargement of the chiasm, as clearly shown
in Fig 9. GBMs are usually hypointense on T1WI and hyper-
intense on T2WI and FLAIR, with enhancement of the solid
component after gadolinium administration.
Extrinsic Lesions
Chordomas.Chordomas are intracranial tumors, especially
in children, that originate from the remnants of primary
notochord and account for 1% of all intracranial tu-
mors.48 They arise most commonly in the clivus, but
extension upward may lead to optic tracts or chiasmal in-
volvement and hypothalamic dysfunction.14 They are slow-
Fig 7. Dermoid cyst. Axial soft-tissue (A) and bone (B) algorithm CT reconstructions; sagittal T1-weighted (C), coronal T2-weighted (D), axial
fat-suppressed T2W FLAIR (E), and postgadolinium T1-weighted (F) images of a dermoid cyst. A 35-year-old patient with an incidental finding of a
pituitary infundibular lesion on a CT of the head performed for trauma. CT of the head in soft-tissue (A) and bone algorithm (B) reconstructions
demonstrates a hypoattenuatedmidline lesion centered in the suprasellar cistern, with associated anterior calcifications. The lesion demonstrates fat
attenuation. MR imaging of the brain was then obtained, which demonstrated the lesion to be centered in the suprasellar cistern along the infundib-
ulum and demonstrated hyperintense signal intensity on T1WI (C) and T2WI (D), hypointense signal intensity on fat-suppressed T2 FLAIR (E), and no
contrast enhancement after gadolinium administration (F). Note the chemical shift artifact along the frequency-encoded direction.
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growing, locally aggressive tumors. The treatment of choice
is surgery, and endoscopic techniques in skull base surgery
have provided higher rates of tumor removal.48 Postopera-
tive radiation therapy is useful, though high doses are re-
quired. CT may show a soft-tissue mass with bone destruc-
tion and, in 50% of patients, ossification. MR imaging
exceeds CT in both identifying tumor expansion and the
relationship to adjacent structures (Fig 10). On T1WI, sig-
nal intensity is variable according to the expansion of the
tumor into the bone marrow, which leads to hyperintense
signal intensity. On T2WI, lesions are hyperintense as well,
with hypointense stripes representing septa of fibrous con-
nective tissue. Contrast enhancement is significant and in-
homogeneous both on CT and MR imaging.
Germinomas.Germinomas are rare tumors, predominantly
seen in early adult life. Germinomas are also known as
dysgerminomas or extragonadal seminomas and tend to
arise mostly in the pineal region but may also be seen in the
suprasellar region, at the level of the floor of the third ven-
tricle, or from the optic chiasm.49 Germinomas are locally
invasive and can recur or metastasize. Those that arise
within the sellar region present with visual disturbances
and hypothalamic dysfunction, in particular, diabetes in-
Fig 8. Planum sphenoidale meningioma. Axial T2 FLAIR (A); coronal T1WI (B); sagittal T2WI (C); and axial (D), coronal (E), and sagittal (F) postgado-
linium T1WI of a planum sphenoidale meningioma. A 37-year-old man with headache and bitemporal hemianopia. The MR imaging shows a lesion
centered on the planum sphenoidale, with compression of the pituitary gland and displacement of the optic chiasm.
Fig 9. Bilateral optic nerve glioma. Postgadolinium axial (A) and coronal (B) T1WIs with fat saturation, and coronal (C) postgadolinium T1WI in a
patient with a bilateral optic nerve and chiasm glioma. A 53-year-old man with a history of vision deterioration. MR imaging demonstrates a bilateral
optic nerve glioma with retro-orbital extension and involvement of the optic chiasm.
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sipidus.49 Surgical treatment includes biopsy, followed
by radiation therapy. CT shows hyperattenuated tissue
compared with adjacent normal parenchyma; there is
avid enhancement after contrast medium administration.
MR imaging (Fig 11) shows a soft-tissue mass that is
isointense or slightly hyperintense on T1WI and T2WI
compared with the normal adjacent brain. The peritu-
moral region may show areas of edema or hemorrhage.
As on CT, there is avid enhancement after gadolinium
administration.
Other GermCell Tumors.Although rare, teratoma, embry-
onal cell carcinoma, yolk sac tumors, and choriocarcinoma
can all arise in the optic nerves and chiasm. Intracranial
germ cell tumors are often of mixed histologic composition,
and only teratomas and germinomas are likely to be pure
tumor types. It is thought that these tumors are all associ-
ated with chromosomal defects.50 Some teratomas are be-
nign, while others can be locally invasive. The prognosis is
good for benign tumors that are completely removed; em-
bryonal cell carcinoma, however, is a highly malignant tu-
Fig 10. Chordoma. Axial unenhanced T1WI (A); and axial (B), coronal (C), and sagittal (D) postgadoliniumT1WI of a chordoma. A 19-year-oldmanwith
a history of hypothalamic pituitary dysfunction and growth hormone deficiency. MR imaging demonstrates a lesion into the pituitary sellae, with no
contact with the optic chiasm.
Fig 11. Germinoma. Axial FLAIR (A) and T2WI (B); coronal T1WI (C); and postgadolinium axial (D), sagittal (E), and coronal (F) T1WIs of a germinoma.
An 11-year-old child with a history of polyuria, polydipsia, and vision loss. MR imaging demonstrates a suprasellar mass with a lobulated appearance
that enhances homogeneously. The optic chiasm is difficult to separate from the mass.
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mor with a poor response to treatment. Yolk sac tumors
may also arise in the midline similar to other germ cell
tumors and often share pathologic features with choriocar-
cinoma and embryonal carcinoma. Their prognosis is poor
despite surgery and chemoradiation. Choriocarcinoma is
rare as an isolated intracranial mass.14 These tumors have
no definite specific characteristics, but teratomas on CT can
show fat and calcification, as well as cystic and solid com-
ponents. On MR imaging, teratomas are quite inhomoge-
neous due to their different components; indeed, lesions can
show hyperintense T1WI areas owing to fat or protein-
aceous fluid, intermediate signal intensity owing to soft tis-
sue, and hypointense signal intensity owing to calcification
and blood products. The solid tissue components may en-
hance after gadolinium administration.
Hemangiopericytomas.Hemangiopericytoma is a rare vas-
cular neoplasm that originates in the pericytes in the
walls of capillaries. Intracranial hemangiopericytomas
are aggressive in nature and can originate in the sellae.
The treatment is surgery, often supplemented by radia-
tion therapy. At MR imaging (Fig 12), they can mimic an
adenoma and can be misdiagnosed. On postgadolinium
images, hemangiopericytomas show rather homogeneous
enhancement, though an area of necrosis could be pres-
ent at the core.
Metastases. Metastases in the pituitary gland are rare
and, unless a metastatic systemic disease is already
known, they are often preoperatively misdiagnosed as
pituitary adenomas. The most common types of malig-
nant tumors seen in the sellar and parasellar regions are
breast and lung metastases in women and men, respec-
tively.51 Despite this, almost every primary cancer could
metastasize to those regions (though quite rarely). Clin-
ical presentation may include hormonal dysfunction,
such as diabetes insipidus and panhypopituitarism, and
symptoms owing to chiasmatic compression. There are
no specific criteria to label a lesion in this area as a
metastasis; however, metastases exhibit the same charac-
teristics of deposits seen elsewhere in the brain and char-
acteristic patterns of enhancement.
INFECTIVE DISEASES
Intrinsic Lesions
Tuberculosis. TB generally affects the lungs but can spread
throughout the body and infiltrate the sellar region as well.
The 2 most common presentations in this region are within
the pituitary gland (tuberculoma) or optochiasmal arach-
noiditis; both can cause visual symptoms and pituitary hy-
pofunction due to chiasmal compression.52 Tuberculoma
masses are difficult to distinguish from other pituitary le-
sions,53 even though the thickening of the pituitary stalk
seems to be more common in TB than elsewhere. MR im-
aging can demonstrate a mass lesion within the pituitary
gland; however, the mass is indistinguishable from other
primary pituitary mass lesions. When TB presents as opto-
chiasmal arachnoiditis, perichiasmal enhancement can be
observed after gadolinium administration.54
Viruses. Isolated chiasmitis associated with viral infections
is rare and has been reported with varicella-zoster virus and
Epstein-Barr virus, especially in patients with acquired im-
munodeficiency syndrome (AIDS) and who are immuno-
compromised.55,56 Clinical symptoms are decreased visual
acuity and visual field defects. Treatment is by IV adminis-
tration of antiviral drugs.
Extrinsic Lesions
Pituitary Abscesses. Although extremely rare, pituitary ab-
scesses are considered a life-threatening disease. They ac-
count for 1% of all pituitary lesions and have the same
frequency in both men and women.57,58 Often misdiag-
nosed as tumors, the origin of these abscesses is unclear.
Their management is mainly surgical. They may occur de
novo or can originate from hematogenous spread or spread
from a contiguous focus of infection, such as meningitis or
Fig 12. Hemangiopericytoma. Axial ADC (A), and axial (B), coronal (C), and sagittal (D) postgadoliniumT1WI of a hemangiopericytoma. A 74-year-old
womanwith a history of bitemporal hemianopia. MR imaging demonstrates an intrasellar hemangiopericytoma, with compression of the optic chiasm
and extension into the sphenoid sinus and cavernous sinus.
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sphenoiditis. Clinical symptoms include headache (70%–
92%); anterior pituitary dysfunction (54%–85%); central
diabetes insipidus (41%–70%); visual disorders due to op-
tic nerves and chiasm involvement (27%–50%); slight or
moderate fever (14%–33%); fever with signs of meningeal
irritation (25%); and nonspecific symptoms of systemic in-
fection, for example, dizziness (10%).59 The most com-
monly isolated pathogens are Staphylococcus species and
Streptococcus species, followed by Neisseria species, Mi-
crococcus, Citrobacter species, Escherichia coli, Brucella,
Salmonella, Corynebacterium, and Mycobacterium.60 MR
imaging is the examination of choice. A sellar or suprasellar
mass is often demonstrated with hypointense signal inten-
sity on T1WI and hyperintense signal intensity on T2WI.
Restricted diffusion at DWI may be seen as common for
intracranial abscesses. After gadolinium administration,
there is ring enhancement, which can mimic the enhance-
ment pattern seen in tumors.
Fungal Infections. Cryptococcosis is the most common op-
portunistic fungal infection of the CNS in patients withHIV
infection and/or AIDS.61Cryptococcus neoformans, in fact,
is a ubiquitous and encapsulated yeast that can affect pa-
tients with severely compromised cell-mediated immunity.
Apart from patients with AIDS, it can affect, though more
rarely, other patients who are compromised, as well as
those with prolonged corticosteroid therapy, chemother-
apy, and lymphomas.62 The spread of cryptococcosis to the
meninges from the sinuses is life-threatening. The most
common clinical form of neurocryptococcosis is meningo-
encephalitis,63 a diffuse brain basal meningitis associated
with a high rate of morbidity and mortality in patients with
AIDS that presents clinically with fever and headache, and
less frequently with confusion, seizure, and meningeal
signs. Corti et al63 also reported a case of sudden blindness
due to invasion and infection of the optic nerves and chiasm
by the fungus in a patient with AIDS. The acute visual loss
in this patient was linked to the presence of cryptococcal
organisms throughout the basal meninges and the sheaths
of the optic nerves and the chiasm.63
Kestelyn et al64 observed papilledema as the most com-
mon clinical manifestation of cryptococcal infection in
32.5% of 80 patients with AIDS, but also observed visual
loss, ocular cranial nerve palsy (9%), and optic nerve atro-
phy (2.5%). In most cases, treatment involves antifungal
therapy, along with management of raised intracranial
pressure. In response to the host immune system attacks on
the organism, the cryptococci produce a mucoid material
that may enlarge the perivascular spaces of Virchow-Robin,
and thus lead to the formation of the cryptococcomas com-
posed of organisms, mucoid material, and inflammatory
cells.65 Involvement of the pituitary gland from other fungi
is uncommon; however, there have been a few cases of
aspergillosis involvement due to sphenoidal sinusitis (Fig
13). MR imaging demonstrates a sellar or suprasellar lesion
that mimics a pituitary adenoma. MR imaging can also
demonstrate punctate hyperintensities that correspondwith
dilated perivascular spaces and cryptococcomas.65 Both
MR imaging and CT tend to underestimate the real exten-
sion of the disease.
Cysticercosis. Cases of sellar neurocysticercosis (NCC) are
rare. So far, little is known about the mechanisms through
which the parasite can attack the optic nerves and pituitary
gland, though they do not differ from the mechanisms pro-
posed for NCC in other areas of the CNS. Therefore, the
mechanisms of sellar involvement range from direct
through indirect invasion to a severe local inflammatory
response.66 Direct invasion of the sella turcica by the NCC
vesicles that affects the hypophysis is the most common
described form reported in the literature67,68 and is often
confused with other more common lesions of the area (eg,
pituitary adenomas and craniopharyngiomas). Clinical
symptoms include visual field deficits and endocrine dys-
functions, but patients can also develop hydrocephalus due
to arachnoiditis, with compromise of the optic chiasm and
Fig 13. Aspergillosis. Axial T2WI (A), and axial (B), sagittal (C), and coronal (D) postgadoliniumT1WI in a patientwith aspergillosis. A 78-year-oldman
with a history of severe sinusitis and II, III, VI nerve palsies after bilateral sphenoidotomies for drainage andwashout of amucopyocele in the sphenoid
sinuses. MR imaging demonstrates a defect in the anterior wall of the sellae (C), throughwhich the postoperative fluid collection in the sphenoid sinus
is continuous with a small pocket of fluid either within or compressing the pituitary gland. The optic chiasm shows a tiny area of enhancement in its
inferior aspect (C and D).
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pituitary stalk.66 Treatment usually consists of the surgical
excision of the lesion, generally through a trans-sphenoidal
approach. On CT, NCC is easily misdiagnosed as a pitu-
itary adenoma with cystic degeneration, a craniopharyngi-
oma, or an arachnoid cyst. MR imaging is more revealing
and shows a hypointense cystic lesion that displaces the
hypophysis laterally and dorsally to the third ventricle and
optic chiasm on postcontrast T1-weighted sequences.66
VASCULAR LESIONS
Intrinsic Lesions
Ischemia. Ischemic infarction of the optic chiasm is rela-
tively rare because of its extensive and redundant collateral
vascular supply that originates from the circle of Willis.69
Two cases of embolic chiasmal infarction have been de-
scribed, one after aortic valve replacement70 and the other
due to atrial fibrillation.71 In both cases, the patients expe-
rienced sudden complete vision loss in one eye with a visual
field defect in the contralateral eye, and with an otherwise
normal neurologic examination.70,71 MR imaging (Fig 14),
and, in particular, DWI and DTI, plays a major role in
detecting ischemia of the visual pathways. DWI may depict
larger lesions of the optic chiasm and optic radiations. DTI,
which uses multiple diffusion directions of analysis and has
a higher signal intensity-to-noise ratio, is sensitive in dem-
onstrating the acute onset and subsequent evolution of vi-
sual pathway ischemia.72 Nevertheless, the necrosis of the
chiasm can be appreciated on T1WI and T2WI.
Extrinsic Lesions
AVFs. Cavernous sinus dural AVFs are arteriovenous
shunts between dural arteries and the cavernous sinus. They
are one of the most common types of intracranial dural
arteriovenous shunts and usually present with benign symp-
toms, such as chemosis and diplopia.73 Despite this, they
may also present with cerebral hemorrhage associated with
cortical venous reflux and require urgent treatment for oc-
clusion of the fistula.73 Carotid-cavernous sinus fistulas
(CCFs) are abnormal communications between the cavern-
ous sinus and the internal carotid. They can be classified
according to 3 criteria: pathologically into spontaneous or
traumatic fistulas, hemodynamically into high-flow or low-
flow fistulas, and angiographically into direct or dural fis-
tulas.74 Traumatic fistulas usually require treatment if there
is progressive visual loss or intolerable headache, or if a
traumatic venous aneurysm enlarges beyond the cavernous
sinus and compresses the optic chiasm.74 CCFs usually
present with diplopia, proptosis, headache, and ocular
pain. The treatment of choice for both cavernous sinus du-
ral AVFs and CCFs includes embolization. Cavernous sinus
dural AVFs can be seen onCTA as abnormally enlarged and
tortuous vessels in the subarachnoid space, which corre-
spond to dilated cortical veins. MR imaging shows dilated
pial vessels in the subarachnoid space (Fig 15). There could
be regions of white matter edema that may also enhance.
These findings are indicative of an aggressive fistula, with a
high rate of hemorrhage. DSA remains the definitive imag-
ing technique. CCFs have similar characteristics but the
clear connection between the cavernous sinus and the inter-
nal carotid is demonstrated.
Cavernous Malformations. Cavernous hemangiomas or
cavernous malformations are histologically benign vascular
malformations composed of capillary tangles. They can oc-
cur anywhere in the brain and spinal cord but have been
reported most frequently at subcortical sites in the frontal
and temporal lobes.75 They can be spontaneous, syn-
dromic, or familial, with the familial form often associated
with multiple cavernous malformations. The familial form
is also reported in association with chiasmal cavernousmal-
formations.76 Cavernous malformations affect approxi-
mately 0.5% of the population, with only a small fraction
of these having optochiasmatic cavernousmalformations.77
Cavernous malformations of the cavernous sinus can ex-
tend into the sellar or parasellar region. The presenting
Fig 14. Apoplexy. Axial postgadolinium T1WI (A) and T2WI (B), and coronal T1WI (C) and postgadolinium T1WI (D) in a patient with apoplexy. An
82-year-old man with sudden onset of panhypopituitarism. MR imaging of the brain (A–C) demonstrates a markedly enlarged pituitary gland with
heterogeneous signal intensity; the optic chiasm is cranially displaced. The postgadolinium T1WI (D) demonstrates peripheral enhancement, albeit
difficult to appreciate due to the intrinsic high signal intensity on T1WI.
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symptoms in these cases range from patients with asymp-
tomatic lesions to patients with gradually progressive visual
loss or pituitary dysfunction, to patients who present
acutely with a chiasmatic apoplexy syndrome.78 The differ-
ential diagnosis includes AVMs, aneurysms, optic glioma,
craniopharyngioma, and pituitary apoplexy.77 Treatment
for symptomatic cavernous malformations is surgical. MR
imaging is the imaging study of choice and demonstrates the
typical heterogeneous signal intensities that reflect blood
deposits of different ages.78 It can show a lobulated mass
that extends from the cavernous sinus. Signal intensity is
usually high on T2WI and low onT1WI; vivid enhancement
is demonstrated after gadolinium administration.
Aneurysms. Internal carotid artery–ophthalmic artery an-
eurysms represent a small proportion of all intracranial an-
eurysms. They account for 0.3%–1% of all intracranial
aneurysms and 0.9%–6.5% of all aneurysms of the internal
carotid artery.79 Yasargil et al80 reported that 18% of pa-
tients with aneurysms of the ophthalmic segment presented
with visual symptoms. Ophthalmic artery aneurysms some-
times elevate the optic nerve or optic chiasm, and, in cases
of large or giant aneurysms, the optic apparatus can be
thinned. There have been only a few cases reported in the
literature of complete optic nerve penetration by an unrup-
tured ophthalmic artery aneurysm.81-84 Takagi and Miy-
amoto85 reported the first case of falciform ligament pene-
tration by an ophthalmic artery aneurysm, which thusmade
anterior clinoidectomy necessary during the surgical proce-
dure to allow the optic canal unroofing and clipping of the
aneurysm. Similar to other intracranial aneurysms, those
that originate from this segment of the internal carotid ar-
tery present with SAH in 20%–70% of patients.86 In addi-
tion, neurologic deficits occur because of the compression
of surrounding visual structures, such as the optic nerves
and chiasm, which thus leads to blurred vision and visual
field impairment.86 Treatment of this kind of aneurysm is
still challenging for neurosurgeons, which results in high
rates of morbidity and mortality. Treatment ranges from
classic clipping of the neck of the aneurysm through trans-
cranial routes (pterional approach and its variants) to en-
dovascular procedures. MR imaging can easily identify the
Fig 15. CCF. Axial T1WI (A), T2WI (B), MRA (C), and cerebral angiogram (D) of a CCF. An 88-year-oldman admitted for status epilepticus. MR imaging
of thebrain (A–C) demonstrates amarkedly enlarged right cavernous segment of the internal carotid arterywith associated severe enlargement of the
right superior ophthalmic vein. There also is arterial flow noted within the right cavernous sinus on the MRA (C) of the brain. There is marked venous
congestion along the right cortical veins with associated venous hypertension and cortical hyperintensity on T2 (B), which is likely the cause of the
seizure in this patient. Cerebral angiogram with right internal carotid artery injection with a subtracted view demonstrates early filling of the right
cavernous sinus, with antegrade flow to the right superior ophthalmic vein toward the facial vein, along with additional venous reflux to the cortical
vein of the right hemisphere, with drainage toward the superior sagittal sinus and the straight sinus.
Fig 16. Internal carotid artery aneurysm. Coronal T2WI (A), axial gradient recalled-echo T2WI (B), and FLAIR (C) in a patient with a right internal
carotid artery aneurysm. A 45-year-oldmanwith a history of headache. Coronal T2WI (A) and axial FLAIR images (C) demonstrate an aneurysmof the
right internal carotid artery. Theoptic chiasm is displaced, and there is an areaof signal intensity change in the T2WI (A) andFLAIR (C),which indicates
edema.
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aneurysm and provide information on the status of the sur-
rounding parenchyma (Fig 16). Cerebral angiography is the
imaging technique of choice. It allows the identification of
the aneurysms and measurement of the neck, which are
useful in planning the surgical clipping or endovascular
treatment.
Compression from Hydrocephalus. Due to the close rela-
tionships between the third ventricle and the optic chiasm,
optic nerve, and cavernous sinus, different neuro-ophthal-
mologic disorders may result from ventricle enlargement.87
Compression of these structures from hydrocephalus may
produce proptosis, ophthalmoplegia, or optic nerve dys-
function. Treatment of these symptoms depends on the
management of the underlying hydrocephalus. CT is the
imaging technique of first choice in the evaluation of en-
larged ventricles. However, it may not always show the
cause of the obstruction, which may be further investigated
with MR imaging.
Traumatic Chiasmal Syndrome. Traumatic damage of the
optic chiasm is uncommon because of its protected location
at the base of the brain. For this reason, brain injury asso-
ciated with damage to the anatomically privileged chiasm is
necessarily severe, which results in damage of surrounding
structures, such as craniofacial bones, the hypothalamic-
pituitary axis, carotid arteries, and cranial nerves.78 Hassan
et al88 reported the largest series of patients with chiasmal
trauma, which consisted of 19 patients evaluated at a single
institution during a 30-year period. The typical patient was
a young adult man after a motor vehicle accident.88 Two-
thirds of the patients had a skull fracture, most commonly a
combined frontal and skull base fracture (31% of patients)
or a frontal bone fracture (21%).88 The most common clin-
ical symptom was severe visual loss with bitemporal hemi-
anopia, which represents the hallmark of traumatic chias-
mal syndrome.88 Other deficits related to optic chiasm
damage may be represented by diabetes insipidus and/or
pituitary dysfunction, anosmia, and oculomotor impair-
ment. Possible mechanisms of chiasmal trauma include
direct tearing, contusion and hemorrhage, necrosis, and
axonal injury.86 There is no specific treatment for trau-
matic chiasmal syndrome, and management of patients is
usually focused on the underlying head trauma. CT is
useful to identify the skull fractures associated with head
trauma. MR imaging in the acute setting, however, is able
to detect asymmetries or transections of the optic chiasm
and hypothalamic lesions.88
SUMMARY
The optic chiasm is a key anatomic structure along the
visual pathway that can be affected by many pathologic
processes, either intrinsic to the optic chiasm itself or ex-
trinsic and arising in one of the many structures present in
this region. We reviewed the imaging findings in a wide
range of diseases that originate from or involve the optic
chiasm to help differentiate the different neuroimaging fea-
tures of lesions in this region of the brain.
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